Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
- 4 June 1999
- Vol. 17 (20-21) , 2612-2619
- https://doi.org/10.1016/s0264-410x(99)00044-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom InfantsThe Journal of Infectious Diseases, 1996
- Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, ChileVaccine, 1995
- Reliability of notification data for childhood bacterial meningitisJournal of Public Health, 1993
- Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilThe Lancet, 1992
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assayVaccine, 1989
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Development of Antibodies to Meningococcal Protein and Lipopolysaccharide Serotype Antigens in Healthy CarriersJournal of Medical Microbiology, 1979
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969